← Leaderboards
Leonardo Mirandola
Kiromic, Inc.
$113,261
Attributed
$226,522
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $224.5K · FY2017–18$250K$187.5K$125K$62.5K$0
'17
'18
Funding mix
By agency
NIH$226,522 · 1
By mechanism
R41$226,522 · 1
Top collaborators
- Maurizio Chiriva-Internati2 shared
Others in their field
Other Emerging Leaders on “Cancer Vaccines”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,990,252
- Paula Gonzalez-Maya · Fundacion Inciensa$17,061,460
- Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$13,559,983
- Neil King · University Of Washington$9,764,305
- Leonard Freedman · Leidos Biomedical Research, Inc.$8,168,768
- Gary Fanger · Rise Therapeutics, Llc$7,793,544
Research focus
Cancer VaccinesActive ImmunizationAcetatesAbateAffectAffinityAggressive BehaviorAdaptive Immune ResponseAntibodiesAdultAntigensAntitumor ResponseAromatase InhibitorsBaseBeta-CyclodextrinsBiological AvailabilityAnimal Cancer ModelBreast Cancer DiagnosisC57bl/6 MouseCancer CellAntibody ResponseCancer SubtypesCancer Testis AntigenCd80 Gene